Results · Jul-Sep 2026 · filed 17 Oct 2026
Bajaj Healthcare Q2 FY27 results
Sales grew 19% to ₹176 crore from ₹148 crore in Jul-Sep 2025.
Operating profit grew 16% to ₹31.2 crore, an operating margin of 17.7% (down 0.5 points from a year ago).
Net profit grew 16% to ₹14.4 crore from ₹12.4 crore in Jul-Sep 2025.
Against Apr-Jun 2026: sales +6%, net profit +4%.
Jul-Sep 2026 vs a year ago
| ₹ crore | Jul-Sep 2026 | Jul-Sep 2025 | Change |
|---|---|---|---|
| Sales | 175.9 | 147.9 | +19% |
| Operating profit (EBITDA) | 31.2 | 26.9 | +16% |
| Operating margin | 17.7% | 18.2% | −0.5 pts |
| Net profit | 14.4 | 12.4 | +16% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 8 quarters
Filings that week
- 19 Oct 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 19 Oct 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 17 Oct 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 17 Oct 2026Compliances- Statement Of Deviation & Variation
- 17 Oct 2026Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- 17 Oct 2026Results-Financial Results For September 30, 2026
- 17 Oct 2026Board Meeting Outcome for Outcome Of The Board Meeting
- 14 Oct 2026Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.